P Autzen

500 total citations
10 papers, 399 citations indexed

About

P Autzen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, P Autzen has authored 10 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in P Autzen's work include Prostate Cancer Treatment and Research (4 papers), Bone health and treatments (2 papers) and Peptidase Inhibition and Analysis (2 papers). P Autzen is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Bone health and treatments (2 papers) and Peptidase Inhibition and Analysis (2 papers). P Autzen collaborates with scholars based in United Kingdom, Sweden and United States. P Autzen's co-authors include Freddie C. Hamdy, Craig Robson, David E. Neal, A J Malcolm, C. H. W. Horne, Mark Johnson, Anders Bjartell, Mary Robinson, Andrew G. Hall and J. Kernahan and has published in prestigious journals such as British Journal of Cancer, The Journal of Pathology and The Prostate.

In The Last Decade

P Autzen

9 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P Autzen United Kingdom	7	250	213	115	89	37	10	399
Neşe Güney Türkiye	12	119 0.5×	123 0.6×	74 0.6×	59 0.7×	19 0.5×	20	347
Charles R. Sikes United States	10	122 0.5×	175 0.8×	262 2.3×	72 0.8×	26 0.7×	12	402
Deog Yeon Jo South Korea	11	162 0.6×	232 1.1×	27 0.2×	48 0.5×	71 1.9×	31	447
P. G. Knapstein Germany	10	84 0.3×	139 0.7×	33 0.3×	82 0.9×	9 0.2×	24	339
Elisa Bacillo Italy	10	121 0.5×	210 1.0×	246 2.1×	43 0.5×	31 0.8×	19	468
Egbert J.A. Gerritsen Netherlands	7	251 1.0×	166 0.8×	41 0.4×	69 0.8×	42 1.1×	8	390
Jin Haeng Chung South Korea	13	148 0.6×	153 0.7×	105 0.9×	61 0.7×	47 1.3×	36	435
Makiko Yasumoto Japan	12	211 0.8×	146 0.7×	89 0.8×	46 0.5×	55 1.5×	36	461
Hanguang Hu China	15	113 0.5×	348 1.6×	114 1.0×	98 1.1×	43 1.2×	47	533
Alex Rufle Switzerland	9	96 0.4×	196 0.9×	79 0.7×	60 0.7×	9 0.2×	11	355

Countries citing papers authored by P Autzen

Since Specialization

Citations

This map shows the geographic impact of P Autzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Autzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Autzen more than expected).

Fields of papers citing papers by P Autzen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Autzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Autzen. The network helps show where P Autzen may publish in the future.

Co-authorship network of co-authors of P Autzen

This figure shows the co-authorship network connecting the top 25 collaborators of P Autzen. A scholar is included among the top collaborators of P Autzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Autzen. P Autzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Robson, Craig, et al.. (2000). Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue. The Prostate. 42(1). 18–25. 58 indexed citations

2.

Robson, Craig, et al.. (2000). Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue. The Prostate. 42(1). 18–18.

3.

Autzen, P, et al.. (1998). The immunohistochemical detection of cripto-1 in benign and malignant human bladder. The Journal of Pathology. 185(1). 108–111. 11 indexed citations

4.

Autzen, P, Craig Robson, Anders Bjartell, et al.. (1998). Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies. British Journal of Cancer. 78(9). 1219–1223. 99 indexed citations

5.

Autzen, P, P. V. Birch, Mary Robinson, et al.. (1998). The immunohistochemical detection of cripto‐1 in benign and malignant human bladder. The Journal of Pathology. 185(1). 108–111. 1 indexed citations

6.

Hamdy, Freddie C., et al.. (1997). Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue.. PubMed. 57(19). 4427–31. 100 indexed citations

7.

Horne, C. H. W., et al.. (1997). The expression of waf‐1 , p53 and bcl‐2 in prostatic adenocarcinoma. British Journal of Urology. 79(2). 190–195. 43 indexed citations

8.

Autzen, P, et al.. (1997). Cripto-1 is a tumour specific marker of bladder cancer. 80. 23. 1 indexed citations

9.

Anderson, John, Dina Tiniakos, Gary McIntosh, et al.. (1996). RETINOBLASTOMA PROTEIN IN HUMAN BREAST CARCINOMA: IMMUNOHISTOCHEMICAL STUDY USING A NEW MONOCLONAL ANTIBODY EFFECTIVE ON ROUTINELY PROCESSED TISSUES. The Journal of Pathology. 180(1). 65–70. 24 indexed citations

10.

Hall, Andrew G., P Autzen, A Cattan, et al.. (1994). Expression of mu class glutathione S-transferase correlates with event-free survival in childhood acute lymphoblastic leukemia.. PubMed. 54(20). 5251–4. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact